These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31305147)

  • 41. Drugs for chronic obstructive pulmonary disease.
    Treat Guidel Med Lett; 2010 Nov; 8(99):83-8; quiz 89-90. PubMed ID: 21045755
    [No Abstract]   [Full Text] [Related]  

  • 42. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.
    Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M;
    Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD.
    Anzueto A; Miravitlles M
    Am J Med; 2018 Jun; 131(6):608-622. PubMed ID: 29305841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bronchodilators: current and future.
    Cazzola M; Matera MG
    Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease.
    Campos MA; Wanner A
    Am J Med Sci; 2005 Apr; 329(4):181-9. PubMed ID: 15832101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial.
    Celli B; Anderson JA; Brook R; Calverley P; Crim C; Holmes AP; Martinez FJ; Newby DE; Yates J; Vestbo J;
    Am J Respir Crit Care Med; 2018 Jun; 197(12):1641-1644. PubMed ID: 29412688
    [No Abstract]   [Full Text] [Related]  

  • 48. Emerging therapeutic strategies in COPD.
    Babu KS; Morjaria JB
    Drug Discov Today; 2015 Mar; 20(3):371-9. PubMed ID: 25462534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
    Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Update on current care guidelines: Chronic obstructive pulmonary disease, diagnosis and treatment].
    Duodecim; 2010; 126(3):317-9. PubMed ID: 20402041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does tiotropium reduce hospitalizations in chronic obstructive pulmonary disease?
    Oba Y
    Ann Intern Med; 2008 Apr; 148(8):626; author reply 626-7. PubMed ID: 18413628
    [No Abstract]   [Full Text] [Related]  

  • 54. Choice of medications when treating stable COPD.
    Vestbo J
    Clin Respir J; 2010 Oct; 4(4):195-6. PubMed ID: 20887340
    [No Abstract]   [Full Text] [Related]  

  • 55. [Bronchodilator therapy of COPD].
    Kirsten AM; Watz H; Magnussen H
    Dtsch Med Wochenschr; 2014 Feb; 139(6):264-7. PubMed ID: 24473845
    [No Abstract]   [Full Text] [Related]  

  • 56. [Not Available].
    Rothe T
    Ther Umsch; 2019 Nov; 76(6):311-316. PubMed ID: 31762414
    [No Abstract]   [Full Text] [Related]  

  • 57. The challenge of diagnosing a mixed asthma-COPD phenotype (ACOS) in clinical practice.
    García-García Mdel C; Hernández-Borge J; Barrecheguren M; Miravitlles M
    Ther Adv Respir Dis; 2016 Apr; 10(2):175-8. PubMed ID: 26968234
    [No Abstract]   [Full Text] [Related]  

  • 58. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients.
    Wielgat P; Mroz RM; Stasiak-Barmuta A; Szepiel P; Chyczewska E; Braszko JJ; Holownia A
    Adv Exp Med Biol; 2015; 839():1-5. PubMed ID: 25252903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.